For manufacturers of artificial intelligence-enabled Software as a Medical Device (SaMD), the hardest compliance question in 2026...
510(k)
When a machine learning model learns to read chest X-rays better than its previous version, regulatory teams...
Deciding whether to choose QMS or De Novo for SaMD in trials is one of the most...
When a digital health company plans a clinical trial for a new medical device, the first strategic...
Securing FDA approval for a low-cost digital therapeutics (DTx) platform is a formidable but achievable goal. By...
For founders building the next generation of evidence‑based digital therapeutics, the 2024 FDA approval pathway can feel...